Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR

Journal of General Physiology

Volumn 144, Issue 2, 2014, Pages 159-179

  Cui, Guiying ^a   Rahman, Kazi S ^b   Infield, Daniel T ^a   Kuang, Christopher ^a   Prince, Chengyu Z ^a   McCarty, Nael A ^a,b  

^a CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

AMINO ACID SEQUENCE; ANIMAL; CHANNEL GATING; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; EXTRACELLULAR SPACE; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; OOCYTE; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; XENOPUS;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXTRACELLULAR SPACE; HUMANS; ION CHANNEL GATING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN STRUCTURE, TERTIARY; XENOPUS;

EID: 84905394929     PISSN: 00221295     EISSN: 15407748     Source Type: Journal    
DOI: 10.1085/jgp.201311122     Document Type: Article

References (62)

1. Alexander, C., A. Ivetac, X. Liu, Y. Norimatsu, J.R. Serrano, A. Landstrom, M. Sansom, and D.C. Dawson. 2009. Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore. Biochemistry. 48:10078-10088. http://dx.doi.org/10.1021/bi901314c
2. Aller, S.G., J. Yu, A. Ward, Y. Weng, S. Chittaboina, R. Zhuo, P.M. Harrell, Y.T. Trinh, Q. Zhang, I.L. Urbatsch, and G. Chang. 2009. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 323:1718-1722. http://dx.doi.org/10.1126/science.1168750
3. Bagal, S.K., A.D. Brown, P.J. Cox, K. Omoto, R.M. Owen, D.C. Pryde, B. Sidders, S.E. Skerratt, E.B. Stevens, R.I. Storer, and N.A. Swain. 2013. Ion channels as therapeutic targets: a drug discovery perspective. J. Med. Chem. 56:593-624. http://dx.doi.org/10.1021/jm3011433
4. Bai, Y., M. Li, and T.C. Hwang. 2010. Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation. J. Gen. Physiol. 136:293-309. http://dx.doi.org/10.1085/jgp.201010480
5. Cestèle, S., V. Yarov-Yarovoy, Y. Qu, F. Sampieri, T. Scheuer, and W.A. Catterall. 2006. Structure and function of the voltage sensor of sodium channels probed by a beta-scorpion toxin. J. Biol. Chem. 281:21332-21344. http://dx.doi.org/10.1074/jbc.M603814200
6. Chang, X.B., A. Mengos, Y.X. Hou, L. Cui, T.J. Jensen, A. Aleksandrov, J.R. Riordan, and M. Gentzsch. 2008. Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator. J. Cell Sci. 121:2814-2823. http://dx.doi.org/10.1242/jcs.028951
7. Cotten, J.F., and M.J. Welsh. 1999. Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR. Evidence for disruption of a salt bridge. J. Biol. Chem. 274:5429-5435. http://dx.doi.org/10.1074/jbc.274.9.5429
8. - ion pore revealed by distributions of open channel burst durations. Proc. Natl. Acad. Sci. USA. 107:1241-1246. http://dx.doi.org/10.1073/pnas.0911061107
9. Cui, G., Z.R. Zhang, A.R. O'Brien, B. Song, and N.A. McCarty. 2008. Mutations at arginine 352 alter the pore architecture of CFTR. J. Membr. Biol. 222:91-106. http://dx.doi.org/10.1007/s00232-008-9105-9
10. Cui, G., B. Song, H.W. Turki, and N.A. McCarty. 2012. Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers. Pflugers Arch. 463:405-418. http://dx.doi.org/10.1007/s00424-011-1035-1
11. Cui, G., C.S. Freeman, T. Knotts, C.Z. Prince, C. Kuang, and N.A. McCarty. 2013. Two salt bridges differentially contribute to the maintenance of cystic fibrosis transmembrane conductance regulator (CFTR) channel function. J. Biol. Chem. 288:20758-20767. http://dx.doi.org/10.1074/jbc.M113.476226
12. DeCaen, P.G., V. Yarov-Yarovoy, Y. Zhao, T. Scheuer, and W.A. Catterall. 2008. Disulfide locking a sodium channel voltage sensor reveals ion pair formation during activation. Proc. Natl. Acad. Sci. USA. 105:15142-15147. http://dx.doi.org/10.1073/pnas.0806486105
13. Delaunay, A., X. Gasull, M. Salinas, J. Noël, V. Friend, E. Lingueglia, and E. Deval. 2012. Human ASIC3 channel dynamically adapts its activity to sense the extracellular pH in both acidic and alkaline directions. Proc. Natl. Acad. Sci. USA. 109:13124-13129. http://dx.doi.org/10.1073/pnas.1120350109
14. El Hiani, Y., and P. Linsdell. 2012. Tuning of CFTR chloride channel function by location of positive charges within the pore. Biophys. J. 103:1719-1726. http://dx.doi.org/10.1016/j.bpj.2012.09.020
15. Fuller, M.D., Z.R. Zhang, G. Cui, and N.A. McCarty. 2005. The block of CFTR by scorpion venom is state-dependent. Biophys. J. 89:3960-3975. http://dx.doi.org/10.1529/biophysj.105.060731
16. Fuller, M.D., C.H. Thompson, Z.R. Zhang, C.S. Freeman, E. Schay, G. Szakács, E. Bakos, B. Sarkadi, D. McMaster, R.J. French, et al. 2007. State-dependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin. J. Biol. Chem. 282:37545-37555. http://dx.doi.org/10.1074/jbc.M708079200
17. Gabriel, S.E., K.N. Brigman, B.H. Koller, R.C. Boucher, and M.J. Stutts. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 266:107-109. http://dx.doi.org/10.1126/science.7524148
18. Gao, X., Y. Bai, and T.C. Hwang. 2013. Cysteine scanning of CFTR's first transmembrane segment reveals its plausible roles in gating and permeation. Biophys. J. 104:786-797. http://dx.doi.org/10.1016/j.bpj.2012.12.048
19. Gilbert, H.F. 1995. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol. 251:8-28. http://dx.doi.org/10.1016/0076-6879(95)51107-5
20. Glozman, R., T. Okiyoneda, C.M. Mulvihill, J.M. Rini, H. Barriere, and G.L. Lukacs. 2009. N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J. Cell Biol. 184:847-862. http://dx.doi.org/10.1083/jcb.200808124
21. Ha, T.S., H.H. Lim, G.E. Lee, Y.C. Kim, and C.S. Park. 2006. Electrophysiological characterization of benzofuroindole-induced potentiation of large-conductance Ca2+-activated K+ channels. Mol. Pharmacol. 69:1007-1014.
22. Hämmerle, M.M., A.A. Aleksandrov, and J.R. Riordan. 2001. Diseaseassociated mutations in the extracytoplasmic loops of cystic fibrosis transmembrane conductance regulator do not impede biosynthetic processing but impair chloride channel stability. J. Biol. Chem. 276:14848-14854. http://dx.doi.org/10.1074/jbc.M011017200
23. Hanrahan, J.W., J.A. Tabcharani, F. Becq, C.J. Mathews, O. Augustinas, T.J. Jensen, X.B. Chang, and J.R. Riordan. 1995. Function and dysfunction of the CFTR chloride channel. Soc. Gen. Physiol. Ser. 50:125-137.
24. Hingorani, M.M., L.B. Bloom, M.F. Goodman, and M. O'Donnell. 1999. Division of labor-sequential ATP hydrolysis drives assembly of a DNA polymerase sliding clamp around DNA. EMBO J. 18:5131-5144. http://dx.doi.org/10.1093/emboj/18.18.5131
25. Hunt, J.F., C. Wang, and R.C. Ford. 2013. Cystic fibrosis transmembrane conductance regulator (ABCC7) structure. Cold Spring Harb Perspect Med. 3:a009514. http://dx.doi.org/10.1101/cshperspect.a009514
26. Hwang, T.C., and K.L. Kirk. 2013. The CFTR ion channel: gating, regulation, and anion permeation. Cold Spring Harb Perspect Med. 3:a009498. http://dx.doi.org/10.1101/cshperspect.a009498
27. Jordan, I.K., K.C. Kota, G. Cui, C.H. Thompson, and N.A. McCarty. 2008. Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters. Proc. Natl. Acad. Sci. USA. 105:18865-18870. http://dx.doi.org/10.1073/pnas.0806306105
28. Kristidis, P., D. Bozon, M. Corey, D. Markiewicz, J. Rommens, L.C. Tsui, and P. Durie. 1992. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am. J. Hum. Genet. 50:1178-1184.
29. Li, M.S., E.A. Cowley, and P. Linsdell. 2012. Pseudohalide anions reveal a novel extracellular site for potentiators to increase CFTR function. Br. J. Pharmacol. 167:1062-1075. http://dx.doi.org/10.1111/j.1476-5381.2012.02041.x
30. Liu, X., S.S. Smith, F. Sun, and D.C. Dawson. 2001. CFTR: covalent modification of cysteine-substituted channels expressed in Xenopus oocytes shows that activation is due to the opening of channels resident in the plasma membrane. J. Gen. Physiol. 118:433-446. http://dx.doi.org/10.1085/jgp.118.4.433
31. McCarty, N.A., and Z.R. Zhang. 2001. Identification of a region of strong discrimination in the pore of CFTR. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L852-L867.
32. - channel by two closely related arylaminobenzoates. J. Gen. Physiol. 102:1-23. http://dx.doi.org/10.1085/jgp.102.1.1
33. McDonough, S., N. Davidson, H.A. Lester, and N.A. McCarty. 1994. Novel pore-lining residues in CFTR that govern permeation and open-channel block. Neuron. 13:623-634. http://dx.doi.org/10.1016/0896-6273(94)90030-2
34. McPhee, J.C., D.S. Ragsdale, T. Scheuer, and W.A. Catterall. 1998. A critical role for the S4-S5 intracellular loop in domain IV of the sodium channel α-subunit in fast inactivation. J. Biol. Chem. 273:1121-1129. http://dx.doi.org/10.1074/jbc.273.2.1121
35. Mornon, J.P., P. Lehn, and I. Callebaut. 2008. Atomic model of human cystic fibrosis transmembrane conductance regulator: membranespanning domains and coupling interfaces. Cell. Mol. Life Sci. 65: 2594-2612. http://dx.doi.org/10.1007/s00018-008-8249-1
36. Mornon, J.P., P. Lehn, and I. Callebaut. 2009. Molecular models of the open and closed states of the whole human CFTR protein. Cell. Mol. Life Sci. 66:3469-3486. http://dx.doi.org/10.1007/s00018-009-0133-0
37. Muanprasat, C., N.D. Sonawane, D. Salinas, A. Taddei, L.J. Galietta, and A.S. Verkman. 2004. Discovery of glycine hydrazide poreoccluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J. Gen. Physiol. 124:125-137. http://dx.doi.org/10.1085/jgp.200409059
38. Norimatsu, Y., A. Ivetac, C. Alexander, N. O'Donnell, L. Frye, M.S.P. Sansom, and D.C. Dawson. 2012. Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator. Mol. Pharmacol. 82:1042-1055. http://dx.doi.org/10.1124/mol.112.080267
39. Price, M.P., H. Ishihara, D.N. Sheppard, and M.J. Welsh. 1996. Function of Xenopus cystic fibrosis transmembrane conductance regulator (CFTR) Cl channels and use of human-Xenopus chimeras to investigate the pore properties of CFTR. J. Biol. Chem. 271:25184-25191. http://dx.doi.org/10.1074/jbc.271.41.25184
40. Rahman, K.S., G. Cui, S.C. Harvey, and N.A. McCarty. 2013. Modeling the conformational changes underlying channel opening in CFTR. PLoS ONE. 8:e74574. http://dx.doi.org/10.1371/journal.pone.0074574
41. Renauld, S., and A. Chraibi. 2009. Role of the C-terminal part of the extracellular domain of the α-ENaC in activation by sulfonylurea glibenclamide. J. Membr. Biol. 230:133-141. http://dx.doi.org/10.1007/s00232-009-9193-1
42. Sauna, Z.E., and S.V. Ambudkar. 2000. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc. Natl. Acad. Sci. USA. 97:2515-2520. http://dx.doi.org/10.1073/pnas.97.6.2515
43. Schmidt, B., L. Ho, and P.J. Hogg. 2006. Allosteric disulfide bonds. Biochemistry. 45:7429-7433. http://dx.doi.org/10.1021/bi0603064
44. Sebastian, A., L. Rishishwar, J. Wang, K.F. Bernard, A.B. Conley, N.A. McCarty, and I.K. Jordan. 2013. Origin and evolution of the cystic fibrosis transmembrane regulator protein R domain. Gene. 523:137-146. http://dx.doi.org/10.1016/j.gene.2013.02.050
45. Serohijos, A.W., T. Hegedus, A.A. Aleksandrov, L. He, L. Cui, N.V. Dokholyan, and J.R. Riordan. 2008. Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc. Natl. Acad. Sci. USA. 105:3256-3261. http://dx.doi.org/10.1073/pnas.0800254105
46. - channels with altered pore properties. Nature. 362:160-164. http://dx.doi.org/10.1038/362160a0
47. Shi, S., D.D. Ghosh, S. Okumura, M.D. Carattino, O.B. Kashlan, S. Sheng, and T.R. Kleyman. 2011. Base of the thumb domain modulates epithelial sodium channel gating. J. Biol. Chem. 286:14753-14761. http://dx.doi.org/10.1074/jbc.M110.191734
48. Sonawane, N.D., J. Hu, C. Muanprasat, and A.S. Verkman. 2006. Luminally active, nonabsorbable CFTR inhibitors as potential therapy to reduce intestinal fluid loss in cholera. FASEB J. 20: 130-132.
49. Springauf, A., P. Bresenitz, and S. Gründer. 2011. The interaction between two extracellular linker regions controls sustained opening of acid-sensing ion channel 1. J. Biol. Chem. 286:24374-24384. http://dx.doi.org/10.1074/jbc.M111.230797
50. + channel mechanism revealed by the acid-sensing ion channel 1 structure. IUBMB Life. 60:620-628. http://dx.doi.org/10.1002/iub.89
51. Sullivan, L.P., D.P. Wallace, and J.J. Grantham. 1998. Epithelial transport in polycystic kidney disease. Physiol. Rev. 78:1165-1191.
52. Thiagarajah, J.R., and A.S. Verkman. 2013. Chloride channeltargeted therapy for secretory diarrheas. Curr. Opin. Pharmacol. 13:888-894. http://dx.doi.org/10.1016/j.coph.2013.08.005
53. Van Goor, F., S. Hadida, P.D. Grootenhuis, B. Burton, D. Cao, T. Neuberger, A. Turnbull, A. Singh, J. Joubran, A. Hazlewood, et al. 2009. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. USA. 106:18825-18830. http://dx.doi.org/10.1073/pnas.0904709106
54. + channel voltage sensor. Proc. Natl. Acad. Sci. USA. 108:15426-15431. http://dx.doi.org/10.1073/pnas.1112320108
55. Wang, W., G. Li, J.P. Clancy, and K.L. Kirk. 2005. Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs. J. Biol. Chem. 280:23622-23630. http://dx.doi.org/10.1074/jbc.M503118200
56. Weatherall, K.L., V. Seutin, J.F. Liégeois, and N.V. Marrion. 2011. Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calciumactivated potassium (SK) channels. Proc. Natl. Acad. Sci. USA. 108:18494-18499. http://dx.doi.org/10.1073/pnas.1110724108
57. Xu, X., M. Jiang, K.L. Hsu, M. Zhang, and G.N. Tseng. 2008. KCNQ1 and KCNE1 in the IKs channel complex make state-dependent contacts in their extracellular domains. J. Gen. Physiol. 131:589-603. http://dx.doi.org/10.1085/jgp.200809976
58. Yu, H., B. Burton, C.J. Huang, J. Worley, D. Cao, J.P. Johnson Jr., A. Urrutia, J. Joubran, S. Seepersaud, K. Sussky, et al. 2012. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J. Cyst. Fibros. 11:237-245. http://dx.doi.org/10.1016/j.jcf.2011.12.005
59. + channels. J. Biol. Chem. 287:30719-30728. http://dx.doi.org/10.1074/jbc.M112.370742
60. Zhang, Z.R., G. Cui, X. Liu, B. Song, D.C. Dawson, and N.A. McCarty. 2005a. Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel. One polypeptide forms one pore. J. Biol. Chem. 280:458-468. http://dx.doi.org/10.1074/jbc.M409626200
61. Zhang, Z.R., B. Song, and N.A. McCarty. 2005b. State-dependent chemical reactivity of an engineered cysteine reveals conformational changes in the outer vestibule of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 280:41997-42003. http://dx.doi.org/10.1074/jbc.M510242200
62. Zhou, J.J., M. Fatehi, and P. Linsdell. 2008. Identification of positive charges situated at the outer mouth of the CFTR chloride channel pore. Pflugers Arch. 457:351-360. http://dx.doi.org/10.1007/s00424-008-0521-6